Alembic Pharmaceuticals Limited announced that it has received PAS (Prior Approval Supplement) approval from the US Food Drug Administration (USFDA) for its supplemental Abbreviated New Drug Application (sANDA) Pregabalin capsules, 25 mg, 50 mg,...
BeatO, a comprehensive digital diabetes care platform for controlling and reversing diabetes, has announced the appointment of Dr. Navneet Agrawal as its chief clinical officer. Dr. Navneet Agrawal will head BeatO’s proprietary Diabetes Care...
Centre for Cellular and Molecular Platforms (C-CAMP) an initiative supported by Department of Biotechnology is delighted to announce a next-generation Indo-Dutch bilateral collaboration to address the challenge posed by antimicrobial resistance...
The All India Institute of Ayurveda has organised a national workshop today on Ayurveda Nephorology - Vrikka Sambhashna...
Guerison, a global pharmaceutical company having a surgical business in Dubai, is setting its footprints in India’s ophthalmology market with the highest ethics, top development, and utmost safety standards...
EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced that it had raised €21 million in a Series B financing round...
Dr Reddy’s Laboratories Ltd, a global pharmaceutical company, announced that its tocilizumab biosimilar candidate, DRL_TC, successfully met its primary and secondary endpoints in a phase 1 study. This phase 1 study used a subcutaneous formulation...
Apollo Hospitals, a leading quaternary care hospital, has launched a dedicated free support group and helpline number to support those with colorectal cancer and a stoma clinic....
Clariant is set to expand its Care Chemicals facility in Daya Bay, Huizhou, China, to boost its support for pharmaceutical, personal care, home care, and industrial application customers...
Everest Medicines, a biopharmaceutical company, announced that the company has achieved the preclinical proof-of-concept milestone for its mRNA rabies vaccine programme. This new vaccine candidate for rabies post-exposure prophylactic was...